ABSTRACT Variability between workers is reflected in differences in uptake, metabolism, and excretion of toxic substances, and thus individual response to toxic hazards. It is argued that biological monitoring takes account of these differences enabling individual risk assessments to be made. Risk, however, must be seen in terms of clinical and pathological changes-that is, estimated from morbidity and mortality rates-and so laboratory measurements need to be linked to epidemiological studies before they can be used to indicate acceptable or unacceptable uptake of toxic materials.
Industrial workers differ from each other in size, fitness, work practices, smoking habits, alcohol and drug usage, and nutritional state. There is also a significant genetic variability in the way they can metabolise toxic compounds. In considering the response of a group of workers to exposure to toxic material it is clear that they cannot be thought of as a group of genetically homogeneous rats from a well-designed toxicology study. Thus at a specified level of exposure to a toxic material any group of workers will show great differences in their uptake, absorption, metabolism, and excretion of that material. It It is important to emphasise here that a specific blood lead concentration (say 3-7 ,umol/l-used in the example given in the preceding paragraph) cannot be equated directly with a specific atmospheric exposure. A worker may achieve a blood lead concentration of [3] [4] [5] [6] [7] ,umol/l at relatively low air concentrations by disregard of personal cleanliness, and the raised blood lead concentration may reflect ingestion rather than inhalation. The lack of a direct relation between air levels and biological measurements has been taken as a criticism of biological measurement or as evidence that studies comparing the two sets of data have been inadequately performed. Neither of these criticisms is reasonable as will be shown in the succeeding paragraphs. 3 the results of a study3 to show the relation between dosage of the drug propranolol and the concentration of propranolol in the plasma are presented. This particular study has been selected for discussion because the conditions of dosage and samoling were so well controlled-in total contrast to the conditions imposed on investigators studying exposure/metabolite relations in industrial settings. In the propranolol study exposure (dosage) was continuous, seven days a week, and measurements were not taken until the subjects were under pharmacokinetic steady-state conditions. There was a totally accurate measure of exposure; the nursing staff monitored the subjects while they were taking the tablets, and sampling was performed at a defined sampling time after the preceding dose. The residual variation is remarkably less than in the styrene/mandelic acid study of Norseth2 but is still considerable. At a dose of 500mg/dayof propranolol plasmaconcentrations still range from 300 to 550 ng/ml. This is to be expected from various twin studies that have been reported. These have shown that there is a large genetic component contributing to individual plasma differences after administration of the same amount of drug (for instance, Vessell4). These genetically controlled mechanisms affecting plasma concentration of drugs are the same mechanisms as those controlling plasma concentrations of toxic chemicals and their metabolites.
Inter
In occupational medicine the most precise studies that have been performed are probably those using volunteers exposed to organic solvents in carefully controlled environments. Figure 4 shows the results from a study relating exposure to methylene chloride and its concentration in exhaled air. Although in this type of study the concentration of the organic solvent atmosphere is known precisely (measured continuously by gas chromatography and infrared spectroscopy), blood and breath concentrations still vary considerably at each dose level. This precision of exposure data cannot be obtained in industrial surveys, making exposure chamber data essential for defining inter-individual variation in response to organic solvent exposure.
The degree of biological variability in measurements taken from industrial, experimental, and pharmacological surveys does not invalidate the use of this type of measurement in protecting the workforce and in assessing the exposure of individuals. 
